Medscape
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD). The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio, from Fujirebio Diagnostics, Inc., is for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who show signs …
Read More
FDA Clears First Diagnostic Blood Test for AD
Maribel Badon
18:22
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD). The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio, from Fujirebio Diagnostics, Inc., is for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who show signs
